Continue Reading
Full article on Unknown
Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth
Market Intelligence Analysis
AI-Powered
Why This Matters
Mizuho analyst Ann Hynes raised the price target for Elevance Health (ELV) to $413 from $400, citing peaking healthcare utilization growth, and maintained an Outperform rating.
Market Impact
Market impact analysis based on bullish sentiment with 90% confidence.
Sentiment
Bullish
AI Confidence
90%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Elevance Health Inc. (NYSE:ELV) is one of the cheap S&P 500 stocks to invest in now. On January 9, Mizuho analyst Ann Hynes raised the firm’s price target on Elevance Health to $413 from $400 and maintained an Outperform rating on the shares. As part of its Q4 2025 preview, Mizuho broadly revised price targets […]
Original article published by
Unknown
on January 14, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.